June 11, 2020 7:05pm

FATE on Thursday was down -$3.14 to $29.85 as the offering closed

FATE also expects to sell to Johnson & Johnson Innovation-JJDC, Inc. in a private placement, a number of shares of common stock in an aggregate purchase price of up to $50 million, at a price per share equal to the price to the public in the offering 

Proceeds are approximated at $201.3 million with a "green shoe" of 927,234 shares


FATE commences a 7,108 million shares underwritten public offering of its common stock

Subject to the completion of the offering and the expiration or early termination of applicable waiting periods relating to certain antitrust filings under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... 

FATE also sold to Johnson & Johnson Innovation-JJDC, Inc. in a private placement, a number of shares of common stock in an aggregate purchase price of up to $50 million, at a price per share equal to the price to the public in the underwritten public offering.

 

Jefferies, SVB Leerink, Barclays and Guggenheim Securities acted as joint book-running managers for the offering.  Mizuho Securities acted as lead manager for the offering, and H.C. Wainwright & Co. acted as co-manager for the offering.